Disclosure 0001628280-26-064317-1

SEC FORM 4

$21,204.86

Zentalis Pharmaceuticals, Inc. (ZNTL)

Acquisition (code A) of 9,727 shares at $2.18 per share.

Reporting Person Bruns Ingmar · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 30, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001628280-26-064317 · filed 2026-10-01 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Zentalis Pharmaceuticals, Inc. (ZNTL)." Disclosed 2026-10-01. https://desqlong.com/cards/0001628280-26-064317-1 (retrieved 2026-10-02).